Boston Scientific Closes NxThera Acquisition
Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of NxThera. The…
Arboretum_JDApril 30, 2018
Cardiac Dimensions Takes on Abbott and Edwards in FMR Market
Cardiac Dimensions has raised $39 million to build strong clinical evidence for its Carillon Mitral…
Arboretum_JDApril 30, 2018
Cardiac Dimensions Announces $39 Million Series B Financing for Innovative Device to Treat Patients With Heart Failure
Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for patients with…
Arboretum_JDApril 26, 2018
Pear Therapeutics and Sandoz Announce Deal to Commercialize Prescription Digital Therapeutics
Pear Therapeutics, Inc. today announced a deal with Sandoz, a division of Novartis, to commercialize…
Arboretum_JDApril 19, 2018
Swift Biosciences Launches Accel-Amplicon Plus Cancer Panels for Precision Medicine Initiatives
Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a…
Arboretum_JDApril 18, 2018
Boston Scientific Announces Acquisition Of nVision Medical Corporation
Boston Scientific (NYSE: BSX) today announced that it has acquired nVision Medical Corporation, a privately-held…
Arboretum_JDApril 16, 2018
